Skip to Main Content

Author Details

Andy Stergachis
School of Pharmacy, University of Washington
1980
198
42
PMIDPaper TitleJournal TitlePublished Year
38035539Using design thinking to strengthen the community pharmacist's role in epilepsy care.Epilepsy Behav2024
36862871Safety, immunogenicity, and effectiveness of COVID-19 vaccines for pregnant persons: A protocol for systematic review and meta analysis.Medicine (Baltimore)2023
37156596Pregnancy exposure registries for drugs and vaccines in low-income and middle-income countries: scoping review protocol.BMJ Open2023
37012008Assessing preferences for HIV pre-exposure prophylaxis (PrEP) delivery services via online pharmacies in Kenya: protocol for a discrete choice experiment.BMJ Open2023
37336576Development and evaluation of a continuous quality improvement programme for antimicrobial stewardship in six hospitals in Uganda.BMJ Open Qual2023
37306128Stand-alone model for delivery of oral HIV pre-exposure prophylaxis in Kenya: a single-arm, prospective pilot evaluation.J Int AIDS Soc2023
36585791Effect of tenofovir containing ART on renal function in patients with moderate/severe reduced creatinine clearance at baseline: A retrospective study at two referral hospitals in Namibia.Pharmacol Res Perspect2023
36442488Pregnancy outcomes after first-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials: a systematic review and individual patient data meta-analysis.Lancet2023
36915061Data collection systems for active safety surveillance of vaccines during pregnancy in low- and middle-income countries: developing and piloting an assessment tool (VPASS).BMC Pregnancy Childbirth2023
36908449Online HIV prophylaxis delivery: Protocol for the ePrEP Kenya pilot study.Front Public Health2023
36895656Barriers to and strategies for early implementation of pharmacy-delivered HIV PrEP services in Kenya: An analysis of routine data.Front Reprod Health2023
36759872Identifying and addressing challenges to antimicrobial use surveillance in the human health sector in low- and middle-income countries: experiences and lessons learned from Tanzania and Uganda.Antimicrob Resist Infect Control2023
35203802Point Prevalence Survey of Antibiotic Use across 13 Hospitals in Uganda.Antibiotics (Basel)2022
35712117Preparing for Disease X: Ensuring Vaccine Equity for Pregnant Women in Future Pandemics.Front Med (Lausanne)2022
36109733Safety of single-dose primaquine as a Plasmodium falciparum gametocytocide: a systematic review and meta-analysis of individual patient data.BMC Med2022
36275889Pharmacy deserts and COVID-19 risk at the census tract level in the State of Washington.Vaccine X2022
36285619The effectiveness, feasibility and acceptability of HIV service delivery at private pharmacies in sub-Saharan Africa: a scoping review.J Int AIDS Soc2022
33006803Tenofovir disoproxil fumarate associated nephrotoxicity: a retrospective cohort study at two referral hospitals in Namibia.Pharmacoepidemiol Drug Saf2021
33631435Community pharmacists' role in caring for people living with epilepsy: A scoping review.Epilepsy Behav2021
34493520Protocol for active safety monitoring of a cohort of patients using a dolutegravir-based antiretroviral regimen in Mozambique.BMJ Open2021
34489131Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review.Vaccine2021
34775244Stakeholder perceptions of community pharmacist population health management of people living with epilepsy.Epilepsy Behav2021
34774223Global antibiotic consumption and usage in humans, 2000-18: a spatial modelling study.Lancet Planet Health2021
34127978Safety of COVID-19 vaccines, their components or their platforms for pregnant women: A rapid review.medRxiv2021
34073950Medication Handling and Storage among Pilgrims during the Hajj Mass Gathering.Healthcare (Basel)2021
33478926Strengthening pandemic preparedness through pharmacy and public health collaborations: Findings from a facilitated discussion exercise.J Am Pharm Assoc (2003)2021
32268901First trimester use of artemisinin-based combination therapy and the risk of low birth weight and small for gestational age.Malar J2020
31753615Prescription drug monitoring program use and utility by Washington State pharmacists: A mixed-methods study.J Am Pharm Assoc (2003)2020
31865828Integrating public health students into interprofessional education.J Interprof Care2020
31829065Effect of TDF-containing regimens on creatinine clearance in HIV patients in Namibia with a baseline CrCl <60ml/min; findings and implications.Hosp Pract (1995)2020
33192526National Consumption of Antimicrobials in Tanzania: 2017-2019.Front Pharmacol2020
33323448Antimicrobial use across six referral hospitals in Tanzania: a point prevalence survey.BMJ Open2020
32922144Medication utilization pattern among outpatients during the Hajj mass gathering.Saudi Pharm J2020
32420540Maternal and neonatal data collection systems in low- and middle-income countries: scoping review protocol.Gates Open Res2020
32305209Preparing pharmacy for the surge of patients with COVID-19: Lessons from China.J Am Pharm Assoc (2003)2020
30660320Strengthening the evidence-base on payment models for pharmacist-provided services.J Am Pharm Assoc (2003)2019
30955981Maternal interventions vigilance harmonization in low- and middle-income countries: Stakeholder meeting report; Amsterdam, May 1-2, 2018.Vaccine2019
31170193Estimating the costs of HIV clinic integrated versus non-integrated treatment of pre-cancerous cervical lesions and costs of cervical cancer treatment in Kenya.PLoS One2019
30446177The effects of vaccination forecasts and value-based payment on adult immunizations by community pharmacists.Vaccine2019
28965312A Comparison of Adverse Drug Reaction Profiles in Patients on Antiretroviral and Antitubercular Treatment in Zimbabwe.Clin Drug Investig2018
30219080The quality of anti-malarial medicines in Embu County, Kenya.Malar J2018
30053910A pharmacovigilance system for treatment access and medical donation programs: The Max Foundation experience.Global Health2018
30190107Enhancements to JAPhA.J Am Pharm Assoc (2003)2018
30077566When government agencies turn to unregulated drug sources: Implications for the drug supply chain and public health are grave.J Am Pharm Assoc (2003)2018
29860943Measuring and mapping the global burden of antimicrobial resistance.BMC Med2018
30388156Translating medicines to patients: A novel methodology for quantifying the global medical supplies and donations program.PLoS One2018
30382856Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems.Global Health2018
29615066A qualitative assessment of the challenges of WHO prequalification for anti-malarial drugs in China.Malar J2018
29732641Assessment tool for establishing local pharmaceutical manufacturing in low- and middle-income countries.Int J Pharm Pract2018
29287699From mass gatherings medicine to mass gatherings health: Conclusions from the 3rd International Conference on Mass Gatherings Medicine, Riyadh, Kingdom of Saudi Arabia.Int J Infect Dis2018
  • 1 - 50 of 198

Recommended Authors

Stanford University
Career Start Year 2010
Number of shared co-authors 0
Bayer Pharma AG
Career Start Year 2009
Number of shared co-authors 1
College of Public Health, Taipei Medical University
Career Start Year 2004
Number of shared co-authors 0
Harvard Medical School
Career Start Year 2004
Number of shared co-authors 2
Harvard Medical School and the Harvard Pilgrim Health Care Institute
Career Start Year 2004
Number of shared co-authors 0
St. Jude Children's Research Hospital Memphis
Career Start Year 2003
Number of shared co-authors 0
Oregon Health & Science University-Portland State University School of Public Health
Career Start Year 2002
Number of shared co-authors 0
Northwestern University Feinberg School of Medicine
Career Start Year 2001
Number of shared co-authors 0
McMaster University
Career Start Year 2001
Number of shared co-authors 2
Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center
Career Start Year 2001
Number of shared co-authors 0
University of Washington
Career Start Year 1997
Number of shared co-authors 2
Medical University of South Carolina
Career Start Year 1996
Number of shared co-authors 0
Institute of General Practice and Family Medicine, University Hospital
Career Start Year 1996
Number of shared co-authors 1
Rush University Medical Center
Career Start Year 1995
Number of shared co-authors 1
Virginia Commonwealth University
Career Start Year 1993
Number of shared co-authors 0
Center for Family Medicine
Career Start Year 1993
Number of shared co-authors 0
University Medical Center Utrecht
Career Start Year 1991
Number of shared co-authors 2
University of Michigan ann arbor
Career Start Year 1991
Number of shared co-authors 0
University of Tennessee Health Science Center
Career Start Year 1990
Number of shared co-authors 4
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1990
Number of shared co-authors 1
University of Bristol
Career Start Year 1988
Number of shared co-authors 1
Rutgers University School of Public Health
Career Start Year 1988
Number of shared co-authors 2
Icahn School of Medicine Mount Sinai. New York
Career Start Year 1987
Number of shared co-authors 0
Tufts University School of Medicine
Career Start Year 1986
Number of shared co-authors 0
University of Pennsylvania Perelman School of Medicine
Career Start Year 1985
Number of shared co-authors 2
university of california san diego
Career Start Year 1983
Number of shared co-authors 0
University of Iowa, School of Public Health
Career Start Year 1982
Number of shared co-authors 1
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 0
University of Toronto
Career Start Year 1977
Number of shared co-authors 0
The University of New Mexico
Career Start Year 1977
Number of shared co-authors 0

Collaborators

Co-authored papers 20
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 20
Impact Health LLC
Co-authored papers 12
Co-authored papers 10
Kaiser Permanente Northern California, University of California san francisco
Co-authored papers 3
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Co-authored papers 3
Harvard T.H. Chan School of Public Health
Co-authored papers 3
Harvard Medical School and Harvard Pilgrim Health Care Institute
Co-authored papers 2
Perelman School of Medicine, The University of Pennsylvania
Co-authored papers 2
University of Washington
Co-authored papers 2
Co-authored papers 2
University of Washington
Co-authored papers 2
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 2
Fred Hutchinson Cancer Research Center
Co-authored papers 2
Fred Hutchinson Cancer Research Center
Co-authored papers 2
Co-authored papers 1
University of Washington
Co-authored papers 1
University of Washington
Co-authored papers 1
Yale School of Public Health
Co-authored papers 1
Sydney Institute for Infectious Diseases, The University of Sydney
Co-authored papers 1
Boston Children's Hospital, Harvard Medical School
Co-authored papers 1
The Max Foundation
Co-authored papers 1
Center for Pharmacoepidemiology and Treatment Science, Rutgers University
Co-authored papers 1
University of Washington
Co-authored papers 1
The Max Foundation
Co-authored papers 1
Institute of Nursing Science, University of Basel
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Vanderbilt University Medical Center
Co-authored papers 1
Swedish Neuroscience Institute
Co-authored papers 1